• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

Onchocerciasis Network Meeting

3-4 October 2018

Kampala, Uganda

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

The Onchocerciasis Research Network Meeting took place during the 11th DNDi Partners’ Meeting.

Opening

Date: Wednesday, 3 October 2018
Time:
 08:00-8:15
Venue: Room Royal, Speke Resort and Conference Centre

Welcome & meeting objectives

Sabine Specht, Head of Filariasis Clinical Programme, DNDi, Switzerland


Belén Pedrique, Medical Manager, Filariasis Programme, DNDi, Switzerland

Sessions

Onchocerciasis in Africa

Time: 08:15-10:45

Progress of onchocerciasis programs in Africa and the challenges to reach elimination
Tony Ukety, Former Medical Officer in charge of river blindness, WHO Department of NTDs, & Consultant Ophthalmologist & NTD Expert, DRC

Country-specific situation of clinical trials and research – Ghana
Benjamin Marfo, Deputy NTD Program Manager, Ghana

Cameroon: Country progress towards elimination and research update
Benjamin Didier Biholong, Coordonnateur du Programme National de Lutte contre l’Onchocercose (PNLO), Cameroon

DRC: Country progress towards elimination and research update
Jean-Paul Tambwe, DRC

Uganda: Country progress towards elimination
David W. Oguttu, Programme Manager, Onchocerciasis. NTD Control Programme. Vector Control Division-Ministry of Health. Uganda

Uganda: New vector control methods under research
Thomson Luroni Lakwo, Senior Entomologist. Former Programme Manager-Onchocerciasis. Vector Control Division-Ministry of Health. Uganda

Uganda: Onchocerciasis associated epilepsy and nodding syndrome research
Richard Idro, Head of Paediatric Neurology program at Makerere University College of health sciences/Mulago Hospital. Kampala Uganda

Platforms and Research Centres: Sharing experiences

Time: 11:00-14:30

KCCR Kumasi, Ghana and TAKeOFF platform (Tackling the Obstacle to Fight Filariasis and Podoconiosis)
Alexander Debrah, Associate Professor of Parasitology and Global Health, Kwame Nkrumah University of Science and Technology, & Coordinator TAKeOFF Consortium, Ghana

UHAS
Nick Opoku, Clinical trial PI, Ghana

CRMT Rethy
Tony Ukety, Former Medical Officer in charge of river blindness, WHO Department of NTDs, & Consultant Ophthalmologist & NTD Expert, DRC

REFODTE, Buea Cameroon
Samuel Wanji, Professor of Public Health Parasitology & Entomology, Head of Department of Microbiology & Parasitology. University of Buea, Cameroon

CRFilMT, Yaounde Cameroon and CANTAM
Joseph Kamgno, Director of the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT), Cameroon

NSETHIO project
Bob Colebunders, NSETHIO project, Global Health Institute, Belgium

HAT platform experience
Florent Mbo, HAT Platform Coordinator, DNDi DRC

Current research landscape in onchocerciasis – Part 1

Time: 14:30-15:30

Clinical research in onchocerciasis – DOLF
Peter Fischer, Associate Professor of Medicine, Washington University School of Medicine Infectious Diseases Division Molecular Helminthology & DOLF Project, USA

Clinical research in onchocerciasis – Bonn University
Ute Klarmann-Schulz, Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn. Germany

Clinical research in onchocerciasis – TNT project and other studies
Joseph Kamgno, Director of the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT), Cameroon
Michel Boussinesq, Parasitologist, lnstitut de Recherche pour le Développement (IRD), France

Current research landscape in onchocerciasis – Part 2

Date: Thursday, 4 October 2018
Time:
 8:00-9:00

Alternative Strategies for the Acceleration of Elimination of Onchocerciasis in Cameroon
Samuel Wanji, Professor of Public Health Parasitology & Entomology, Head of Department of Microbiology & Parasitology. University of Buea, Cameroon

Moxidectin studies: community study comparing moxidectin and ivermectin in Ituri, DRC
Annette Kuesel, Scientist, WHO, Switzerland
Michel Mandro, Provincial Division of Health of Ituri, DRC
Tony Ukety, Former Medical Officer in charge of river blindness, WHO Department of NTDs, & Consultant Ophthalmologist & NTD Expert, DRC
Mark Sullivan, Founder and Managing Director of Medicines Development, Australia

Moxidectin pediatric study in Ghana
Annette Kuesel, Scientist, WHO, Switzerland
Nick Opoku, Clinical trial PI, Ghana

Onchocerciasis: What are the patients’ needs?

Time: 9:00-9:30

Unmet Medical Need of onchocerciasis patients and DNDi landscape – Target Product Profile for onchocerciasis case management
Sabine Specht, Head of Filariasis Clinical Programme, DNDi, Switzerland

Registration & access of new drugs in Africa

Time: 9:45-10:15

Moxidectin experience for FDA registration and options for registration in Africa
Annette Kuesel, Scientist, WHO, Switzerland
Mark Sullivan, Founder and Managing Director of Medicines Development, Australia

Access strategies for new treatments
Belén Pedrique, Medical Manager, Filariasis Programme, DNDi, Switzerland

 

Other events

Loading...
8-12 May 2023

Lisbon, Portugal and online

ESPID 2023

13 April 2023, 2 PM London

London, United Kingdom

Ending the neglect of Chagas disease in the UK

11-12 April 2023

Barcelona, Spain and online

XVIII Jornadas sobre la enfermedad de Chagas

27-31 March 2023

Online

Global meeting on skin-related neglected tropical diseases

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo